0001123494 2026-06-08 2026-06-08 0001123494 1 2026-06-08 2026-06-08 0001123494 2 2026-06-08 2026-06-08 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001123494 HARVARD BIOSCIENCE INC N/A false false S-8 HARVARD BIOSCIENCE INC Equity Common Stock, $0.01 par value per share true 400000 6.38 2552000.00 0.0001381 352.43 Equity Common Stock, $0.01 par value per share true 120000 6.38 765600.00 0.0001381 105.73 3317600.00 458.16 0.00 458.16 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers such an indeterminate amount of shares of common stock, par value $0.01 per share ("Common Stock"), as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events. (2) The amount registered consists of up to 400,000 shares of Common Stock issuable pursuant to the Registrant's Employee Stock Purchase Plan, as amended. (3) The proposed maximum offering price per unit is estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common Stock on the Nasdaq Capital Market on June 4, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers such an indeterminate amount of shares of common stock, par value $0.01 per share ("Common Stock"), as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events. (2) The The amount registered consists of up to 120,000 shares of Common Stock issuable pursuant to the Amended and Restated 2021 Incentive Plan. (3) The proposed maximum offering price per unit is estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common Stock on the Nasdaq Capital Market on June 4, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).